These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 10769429)

  • 1. [Osteoporosis in rheumatoid arthritis--significance of alfacalcidol in prevention and therapy].
    Schacht E
    Z Rheumatol; 2000; 59 Suppl 1():10-20. PubMed ID: 10769429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol.
    Schacht E
    Calcif Tissue Int; 1999 Oct; 65(4):317-27. PubMed ID: 10485985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alfacalcidol versus plain vitamin D in inflammation induced bone loss.
    Scharla SH; Schacht E; Lempert UG
    J Rheumatol Suppl; 2005 Sep; 76():26-32. PubMed ID: 16142848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures.
    Schacht E; Richy F; Reginster JY
    J Musculoskelet Neuronal Interact; 2005; 5(3):273-84. PubMed ID: 16172518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation osteoporosis and corticosteroid-induced osteoporosis in autoimmune diseases: experience with alfacalcidol.
    Dequeker J; Borghs H; Van Cleemput J; Nevens F; Verleden G; Nijs J
    Z Rheumatol; 2000; 59 Suppl 1():53-7. PubMed ID: 10769438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
    Ringe JD; Faber H; Fahramand P; Schacht E
    J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of alfacalcidol for reducing increased risk of falls and fractures.
    Ringe JD; Schacht E
    Rheumatol Int; 2009 Aug; 29(10):1177-85. PubMed ID: 19159932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis.
    Ringe JD; Dorst A; Faber H; Schacht E; Rahlfs VW
    Rheumatol Int; 2004 Mar; 24(2):63-70. PubMed ID: 14513268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis.
    Uchiyama Y; Higuchi Y; Takeda S; Masaki T; Shira-Ishi A; Sato K; Kubodera N; Ikeda K; Ogata E
    Bone; 2002 Apr; 30(4):582-8. PubMed ID: 11934649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-hormone analog alfacalcidol: an update on its role in post-menopausal osteoporosis and rheumatoid arthritis management.
    Richy F; Deroisy R; Lecart MP; Hanssens L; Mawet A; Reginster JY
    Aging Clin Exp Res; 2005 Apr; 17(2):133-42. PubMed ID: 15977462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The advantage of alfacalcidol over vitamin D in the treatment of osteoporosis.
    Shiraishi A; Higashi S; Ohkawa H; Kubodera N; Hirasawa T; Ezawa I; Ikeda K; Ogata E
    Calcif Tissue Int; 1999 Oct; 65(4):311-6. PubMed ID: 10485984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol.
    Ringe JD; Schacht E
    Rheumatol Int; 2007 Dec; 28(2):103-11. PubMed ID: 17668216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of glucocorticoid-induced osteoporosis with alfacalcidol/calcium and vitamin D/calcium].
    Ringe JD; Cöster A; Meng T; Schacht E; Umbach R
    Z Rheumatol; 2000 Jun; 59(3):176-82. PubMed ID: 10929446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of corticosteroid-induced osteoporosis by alfacalcidol.
    Lakatos P; Nagy Z; Kiss L; Horvath C; Takacs I; Foldes J; Speer G; Bossanyi A
    Z Rheumatol; 2000; 59 Suppl 1():48-52. PubMed ID: 10769437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies on effect of risedronate and alfacalcidol against glucocorticoid-induced osteoporosis in rheumatoid arthritic patients.
    Yamada S; Takagi H; Tsuchiya H; Nakajima T; Ochiai H; Ichimura A; Iwata H; Toriyama T
    Yakugaku Zasshi; 2007 Sep; 127(9):1491-6. PubMed ID: 17827929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a differential response to alfacalcidol and vitamin D in the treatment of osteoporosis?
    Francis RM
    Calcif Tissue Int; 1997 Jan; 60(1):111-4. PubMed ID: 9030491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relative value of plain vitamin D and of biologically active vitamin D in the prevention and treatment of osteoporosis].
    Scharla S
    Z Rheumatol; 2006 Sep; 65(5):391-4, 396-9. PubMed ID: 16944081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.